Volume 16, Number 9—September 2010
Dispatch
Analysis of Avian Hepatitis E Virus from Chickens, China
Table 1
Primer* | Sequence, 5′ → 3′† | Position, nt‡ |
---|---|---|
F1-1 | CCATGCCAGGGTAAGAATG | 9–27 |
R1-1 | AAAACAGCAAGGACCTCC | 1872–1889 |
F1-2 | CCAGGGTAAGAATGGACG | 14–31 |
R1-2 | TAATCCAGGTGGCGAGC | 1308–1324 |
F2-1 | CACTGTGGGTAACATTGTGGC | 1071–1091 |
R2-1 | GTTCGACTGCTTAGCCACCTG | 2935–2955 |
F2-2 | AGGCGGAACACGCACAGCA | 1214–1232 |
R2-2 | TCGTCCACAATGACCCTGC | 2624–2642 |
F3-1 | GGCTGTGTGGCATGTTCCA | 1985–2003 |
R3-1 | GGTAAAGAGCCACCATCCAAT | 4010–4030 |
F3-2 | CCGTGATGGTGACTTGTTGGTTGT | 2262–2285 |
R3-2 | GGCACATCTCCGCATACTC | 3586–3604 |
F4-1 | CCCTTCAACATTGGAGTATGC | 3573–3593 |
R4-1 | ATCTGGTACCGTGCGAGT | 4899–4916 |
F4-2 | ACATTGGAGTATGCGGAGATG | 3580–3600 |
R4-2 | TTGAGCGCTCCACTGGGCT | 4820–4838 |
F5 | GACAATTCAGCCCAGTGGA G | 4809–4828 |
AUAP§ | GACTCGAGTCGACATCG A | Nonviral |
AP§ | GACTCGAGTCGACATCGA (T)17 | Nonviral |
*Primers F1-1 to R1-2, F2-1 to R2-2, F3-1 to R3-2, and F4-1 to R4-2 were used to amplify the first, second, third, and fourth fragment of the near-complete avian hepatitis E virus (HEV) genome. Primers F5, amplification primer (AUAP), and adapter primer (AP) were used to amplify the extreme 3′ genomic sequence. Primers R1-1, R2-1, R3-1, R4-1, and AP are also reverse transcription primers.
†Sequences of primers were designed according to the sequences of 4 other known avian HEV strains.
‡Positions of primers located in the complete genome are shown according to the Europe avian HEV isolate.
§Commercial primer (Invitrogen, Carlsbad, CA, USA) of nonviral origin.
1Current affiliation: Northwest A&F University, Yangling, People’s Republic of China.
Page created: August 28, 2011
Page updated: August 28, 2011
Page reviewed: August 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.